Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,6 USD | -1,84% | -7,51% | +3,23% |
Vakgebied
Aantal werknemers: 121
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Probody Therapeutics
100,0
%
| 53 | 100,0 % | 101 | 100,0 % | +90,38% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 53 | 100,0 % | 101 | 100,0 % | +90,38% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Sean McCarthy
CEO | Chief Executive Officer | 57 | 01-12-10 |
Chris Ogden
DFI | Director of Finance/CFO | 40 | 02-08-21 |
Marcia Belvin
CTO | Chief Tech/Sci/R&D Officer | 57 | 01-01-18 |
Yu Waye Chu
CTO | Chief Tech/Sci/R&D Officer | 56 | 17-07-23 |
Lloyd Rowland
CMP | Compliance Officer | 67 | 01-05-18 |
Jeffrey Landau
PRN | Corporate Officer/Principal | 46 | 01-04-21 |
Hong He
PRN | Corporate Officer/Principal | 55 | 01-02-20 |
Danielle Olander
HRO | Human Resources Officer | - | 01-08-14 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
James Meyers
BRD | Director/Board Member | 58 | 20-12-18 |
Elaine Jones
BRD | Director/Board Member | 69 | 01-12-14 |
Sean McCarthy
CEO | Chief Executive Officer | 57 | 01-12-10 |
Mani Mohindru
BRD | Director/Board Member | 52 | 16-12-20 |
Halley Gilbert
BRD | Director/Board Member | 54 | 27-04-20 |
Matthew Young
BRD | Director/Board Member | 54 | 01-11-15 |
Alan Ashworth
BRD | Director/Board Member | 63 | 29-09-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 67 731 764 | 66 926 077 ( 98,81 %) | 0 | 98,81 % |
Bedrijfsgegevens
CytomX Therapeutics, Inc.
151 Oyster Point Boulevard Suite 400
94080-1913, South San Francisco
+650 515 3185
http://www.cytomx.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+3,23% | 108 mln. | |
-2,26% | 103 mld. | |
+1,41% | 95,71 mld. | |
+0,93% | 22,02 mld. | |
-17,84% | 20,9 mld. | |
-9,23% | 17,85 mld. | |
-42,83% | 16,21 mld. | |
-17,63% | 15,52 mld. | |
+4,55% | 13,86 mld. | |
+32,11% | 12,04 mld. |
- Beurs
- Aandelen
- Koers CTMX
- Onderneming CytomX Therapeutics, Inc.